From: Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
Characteristics | Before UC-MSC therapy | After UC-MSC therapy | P value |
---|---|---|---|
White blood cell count, × 109/mL (normal range, 3.5–9.5) | 6.72 ± 2.62 | 6.43 ± 1.72 | 0.346 |
Lymphocyte count, × 109/mL (normal range, 1.1–3.2) | 1.09 (0.68–1.35) | 1.43 (1.02–2.20) | < 0.001 |
C-reactive protein, mg/L (normal range, < 10) | 13.39 (1.30–38.86) | 0.50 (0.50–6.40) | 0.003 |
Procalcitonin, ng/mL (normal range, < 0.05) | 0.07 (0.05–0.09) | 0.04 (0.03–0.06) | < 0.001 |
Interleukin-6, pg/mL (normal range, < 7) | 13.78 (5.69–25.26) | 4.86 (2.13–8.19) | < .001 |
D-dimer, ng/mL (normal range, < 243) | 495 (320–727) | 288 (197–537) | 0.010 |
PaO2/FiO2 | 242 (200–294) | 332 (288–364) | < 0.001 |